Menu

As a Partner-Company 2020, we support the work of DOCTORS WITHOUT BORDERS with our donation. In order to donate, our company has been vetted by DOCTORS WITHOUT BORDERS to verify our compliance with their donation guidelines. Our contribution enables DOCTORS WITHOUT BORDERS to save lives worldwide. DOCTORS WITHOUT BORDERS / MÉdECINS SANS FRONTIÈRES  (MSF) DOCTORS WITHOUT BORDERS provides emergency medical relief in areas fraught by crisis, war, or natural catastrophes. The international organisation helps people quickly, effectively and unbureaucratically, irrespective of their race, religion or political orientation. The doctors, midwives, nursing and logistics staff at doctors without borders work in around 70 countries. They treat sick and wounded people, care for undernourished children, and organise clean drinking water and sanitary facilities. For further information: www.msf.org  ...

botiss proudly presents a wonderful organization that offers sustainable care to children affected by cleft lip and palate in more than a dozen countries. botiss will continue to support this valuable work this year - keep up the good work - children are the future! https://www.spaltkinder.org/en.html...

Doctors without borders / Médecins sans Frontières (MSF) provides emergency medical relief in areas fraught by crisis, war, or natural catastrophes. The international organisation helps people quickly, effectively and unbureaucratically, irrespective of their race, religion or political orientation. For further information: www.msf.org...

Vergleich von allogenen und autologen Blöcken zur Kieferkammaugmentation – eine retrospektive radiografische Untersuchung über 12 Monate   Kloss  et al, Clin Oral Implants Res. 2018 Oct 10. doi: 10.1111/clr.13380. [Epub ahead of print] https://www.ncbi.nlm.nih.gov/pubmed/30303581     Studienziel: Retrospektive Studie zur Untersuchung der dreidimensionalen Veränderungen von autogenen und allogenen Blöcken nach Augmentation von Einzelzahndefekten Methode: Die alveolare Knochenbreite an spezifischen Implantatpositionen wurde mittels DVT-Aufnahmen (sagittal und im Querschnitt) vor Augmentation und an drei nachfolgenden Zeitpunkten untersucht. Bei 21 Patienten wurden autologe Knochenblöcke (Entnahme aus der retromolaren Region), bei weiteren 21 Patienten gefriergetrocknete, spongiöse allogene Knochenblöcke verwendet. Ergebnisse: Die vertikalen und horizontalen Abmessungen unterschieden sich zu keinem Zeitpunkt signifikant zwischen autogenen und allogenen Knochenblöcken. Darüber hinaus gab es keine statistisch signifikanten Unterschiede in den Remodelling-Raten zwischen autogenen (mittlere Schrumpfrate nach 12 Monaten: 12,5 ± 7,8 %) und allogenen Onlay-Grafts (mittlere Schrumpfrate nach 12 Monaten: 14,4 ± 9,8 %). Schlussfolgerung: Gefriergetrocknete spongiöse allogene Knochenblöcke zeigten äquivalente volumetrische Schrumpfungsraten wie autogene Knochenblöcke, wenn sie zur Behandlung umschriebener...

Nonincised Papillae Surgical Approach (NIPSA) in Periodontal Regeneration: Preliminary Results of a Case Series. Moreno Rodriguez JA, Caffesse RG. Int J Periodontics Restorative Dent. 2018;38(Suppl):s105-s111. https://www.ncbi.nlm.nih.gov/pubmed/30118534   This case series aims to clinically evaluate a new surgical approach to treat periodontal intrabony defects in conjunction with cerabone® and Emdogain®. Surgically, the defects are accessed via the alveolar mucosa preserving the interdental tissues (Nonincised Papillae Surgical Approach, NIPSA). Methods: Ten patients diagnosed with periodontal intrabony defects with a mean probing pocket depth (PPD) of 9.6 ± 2.3 mm were treated with the Nonincised Surgical Approach (NIPSA) in conjunction with cerabone® and Emdogain®. PPD reduction, clinical attachment level gain (CAL), keratinized tissue width and recessions were recorded six to 18 months post-surgery. Results: Healing was uneventful in all cases. PPD decreased to 2.3 ± 0.5 mm and a CAL gain of 7.3 ± 2.4 mm was found. Gingival papilla height, keratinized tissue width and buccal gingival margin remained stable over time....

The use of mineralized bone allograft (C+TBA) as a single grafting material in maxillary sinus lifting with severely atrophied alveolar ridge (1–3mm) and immediately inserted dental implants. A 3- up to 8-year retrospective study Tilaveridis I. et al, 2018 Oral and Maxillofacial Surgery http://www.ncbi.nlm.nih.gov/pubmed/29858723   OBJECTIVE: The primary aim of our study was to evaluate the efficacy of mineralized bone allograft alone in sinus floor augmentation with simultaneous implant placement in cases with severe atrophy of the residual maxillary bone (bone height < 4 mm). METHODS: Thirty-five dental implants were placed in 29 patients who underwent sinus augmentation via traditional lateral window technique from 2008 to 2013. Patients with residual alveolar height between 1 and 3 mm at the site of implantation were included in the study. The height of residual bone was initially estimated by plain panoramic X-ray and reevaluated intraoperatively by precise micrometric measurement at the site of implantation. Implants of 13 mm height and 3.5...

The Use of a Novel Porcine Derived Acellular Dermal Matrix (mucoderm) in Peri-Implant Soft Tissue Augmentation: Preliminary Results of a Prospective Pilot Cohort Study. Papi P. and Pompa G. BioMed Research International 2018. https://www.hindawi.com/journals/bmri/2018/6406051/   Study aim and design: pilot prospective study to present the one-year follow-up results of mucoderm® in peri-implant soft tissue augmentation procedures dental implants were placed in the upper premolar area of 12 patients, at implant uncovering after 8 weeks mucoderm® was inserted the keratinized mucosa width (KMW) gain was considered as primary outcome variable Results: after 1 month, mean KMW was 7.86±3.22 mm (100%) with no statistically significant intragroup variations no membrane exposures or wound healing complications occurred during the postoperative phase and after one year mean KMW was 5.67±2.12 mm (72.13%). Conclusion: The results of the present pilot study indicate that mucoderm® is suited to augment the periimplant soft tissue and that the results are stable over the assessment period...

Goal: The aim of the study was to histologically determine the role of the repositioned lateral bone window in bone maturation in sinus lift procedure. Furthermore, the osteoconductivity and resorptive behavior of cerabone®, which was used as the sole grafting material, was analyzed. Biopsies were taken ~6 months (group 1) or ~9 months (group 2) after sinus grafting. Main findings: The repositioned bone windows were well integrated and showed bone growing out in direction to the center of the graft, hinting to its osteogenic potential. Newly formed bone was covering most of the surface area of the cerabone® particles, pointing at its excellent osteoconductive potential. A histomorphometric analysis showed no significant differences between both groups regarding new bone formation, connective tissue values or remaining grafting material. TRAP-positive osteoclasts were found on the surface of cerabone® indicating a slow, partial resorption of the bone grafting material. Conclusions: The repositioned bone window showed osteoconductive and limited...

botiss benefits from Straumann’s global distribution and supply network, regulatory resources, and strength as a total solution provider Companies to build further on successful partnership Straumann secures access to botiss’ technology and tightens cooperation   Berlin, 4 July 2018 The Straumann Group has acquired a 30% stake in its biomaterials partner botiss medical AG for an undisclosed sum. botiss is a fast-growing, entrepreneurial company that has already become a leading provider of biomaterials for oral surgery. The acquisition agreement enables Straumann to expand its global distribution network of botiss products. Like the Group’s investment in its CADCAM prosthetics partner Createch (announced today in a separate release), this investment is a further step in the Group’s strategy to become a total solution provider in tooth replacement and esthetic dentistry. Marco Gadola, Chief Executive Officer of the Straumann Group, commented: “botiss has boosted our biomaterials business over the past four years and enables us to...

[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text] Main findings: cerabone® and Bio-Oss® display distinctive physicochemical properties due to a different manufacturing process, in particular differences in the heat treatment the different material properties directly affect the cellular response and healing of the two bone grafting materials a higher number of multinucleated giant cells (MNGCs) was found after implantation of cerabone®, however ongoing research indicates that MNGCs are rather beneficial for the bone healing process on a long-term than a sign of a non-transient inflammatory state cerabone® and Bio-Oss® demonstrated comparable bone formation rates as evidenced by preclinical and clinical data numerous studies suggest only partial resorption of both bone grafts rather than complete remodeling, although there is limited evidence showing that cerabone is more stable Conclusion: cerabone® and Bio-Oss®, although deriving from the same raw material, present with different materials characteristics, cellular responses and healing patterns. Bone formation rates of both bone grafts...